News-Papers
Testimonial
Video Gallery
Search
Follow us...
Latest
- Functional melatonin receptors in human prostate epithelial cells
- Endocrine and immune effects of melatonin therapy in metastatic cancer patients
- A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancer
- Melatonin Regulates Cisplatin Resistance and Glucose Metabolism Through Hippo Signaling in Hepatocellular Carcinoma Cells
- Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas
- Fatty acid metabolism in breast cancer subtypes
- Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours
- The p85α regulatory subunit of PI3K mediates cAMP-PKA and retinoic acid biological effects on MCF7 cell growth and migration
- Bladder cancer: total antioxidant capacity and pharmacotherapy with vitamin-E
- Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt/β-catenin signaling pathway
- Vitamin D, magnesium, calcium, and their interaction in relation to colorectal cancer recurrence and all-cause mortality
- Targeting cancer stem cells by melatonin: Effective therapy for cancer treatment
- Efficacy of oral retinoids for keratoacanthoma centrifugum marginatum
- The regulatory role of melatonin in skeletal muscle
- Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer
- Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals
- 1,25(OH)2-D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production
- Effect of hyperthermia in combination with vitamin E and cyclic AMP on neuroblastoma cells in culture
Most Read
- All-trans-retinoic acid and cancer
- The Di Bella Method (DBM)
- About melatonin - 1996
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Bibliography
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Frequently Asked Questions
- Vademecum
- How effective is chemo therapy?
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
- Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathways